EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro
Mesenchymal stromal cells (MSCs) have demonstrated therapeutic potential in diverse clinical settings, largely due to their ability to produce extracellular vesicles (EVs). These EVs play a pivotal role in modulating immune responses, transforming pro-inflammatory cues into regulatory signals that f...
Main Authors: | Tobias Tertel, Robin Dittrich, Pierre Arsène, Arne Jensen, Bernd Giebel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1282860/full |
Similar Items
-
iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
by: Hae-Ri Lee, et al.
Published: (2023-01-01) -
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01) -
Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome
by: Chin, Eunice W. M., et al.
Published: (2016) -
Particulate matter from car exhaust alters function of human iPSC-derived microglia
by: Henna Jäntti, et al.
Published: (2024-02-01) -
Comparison of two protocols for the generation of iPSC-derived human astrocytes
by: Patrycja Mulica, et al.
Published: (2023-09-01)